{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:19:18Z","timestamp":1771067958741,"version":"3.50.1"},"reference-count":249,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Analytical Chemistry"],"DOI":"10.1080\/10408347.2026.2623483","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:58:57Z","timestamp":1771066737000},"page":"1-28","source":"Crossref","is-referenced-by-count":0,"title":["Analytical Strategies for Fixed-Dose Combination Containing Teneligliptin, Dapagliflozin, and Metformin: A Review"],"prefix":"10.1080","author":[{"given":"Sanjana","family":"Devda","sequence":"first","affiliation":[{"name":"Department of Quality Assurance, Parul Institute of Pharmacy and Research, Parul University","place":["Vadodara, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kotadiya","sequence":"additional","affiliation":[{"name":"Department of Quality Assurance, Parul Institute of Pharmacy and Research, Parul University","place":["Vadodara, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01951-9"},{"key":"e_1_3_5_3_1","doi-asserted-by":"crossref","first-page":"e202400208","DOI":"10.1002\/sscp.202400208","article-title":"Analytical Technique Advances for Recently Approved Fixed\u2010Dose Combination of Dapagliflozin and Teneligliptin Hydrobromide Hydrate","volume":"8","author":"Himani A.","year":"2025","unstructured":"Himani, A.; Rajendra, K. Analytical Technique Advances for Recently Approved Fixed\u2010Dose Combination of Dapagliflozin and Teneligliptin Hydrobromide Hydrate. Sep Sci Plus 2025, 8, e202400208.","journal-title":"Sep Sci Plus"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412919666221025103613"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2024.2400199"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2020.1855411"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-025-01620-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S35682"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcoa.2024.100123"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30102155"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scca.2025.100161"},{"key":"e_1_3_5_12_1","first-page":"223","article-title":"Teneligliptin: A Literature Review on Analytical and Bio-Analytical Methods","volume":"8","author":"Behera S.","year":"2021","unstructured":"Behera, S.; Mohapatra, A.; Sahu, P.; Mishra, T.; Chintapalli, G.; Mishra, D. K.; Amin, R. Teneligliptin: A Literature Review on Analytical and Bio-Analytical Methods. Eur J Pharm Med Res 2021, 8, 223\u2013228.","journal-title":"Eur J Pharm Med Res"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v14i11.6895"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/2472555219859845"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.12806716"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.31788\/RJC.2024.1749032"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.48047\/AFJBS.6.14.2024.9162-9176"},{"key":"e_1_3_5_18_1","first-page":"10","article-title":"UV Spectrophotometric Method Development and Validation for Metformin Hydrochloride in Bulk and Its Tablet Formulation","volume":"8","author":"Bhadru B.","year":"2023","unstructured":"Bhadru, B.; Tadikonda, R.; Bharath, J. UV Spectrophotometric Method Development and Validation for Metformin Hydrochloride in Bulk and Its Tablet Formulation. Chem Res J 2023, 8, 10\u201315.","journal-title":"Chem Res J"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.13189\/app.2024.120404"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09384-6"},{"key":"e_1_3_5_21_1","volume-title":"Essentials of Medical Pharmacology","author":"Tripathi K. D.","year":"2018","unstructured":"Tripathi, K. D. Essentials of Medical Pharmacology; Jaypee Brothers Medical Publishers, New Delhi, India, 2018."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.20253717"},{"key":"e_1_3_5_23_1","volume-title":"Indian Pharmacopoeia","author":"Indian Pharmacopoeia Commission","year":"2022","unstructured":"Indian Pharmacopoeia Commission. Indian Pharmacopoeia; Indian Pharmacopoeia Commission, Ghaziabad, India, 2022."},{"key":"e_1_3_5_24_1","volume-title":"British Pharmacopoeia","author":"British Pharmacopoeia Commission","year":"2009","unstructured":"British Pharmacopoeia Commission. British Pharmacopoeia; Medicines and Healthcare products Regulatory Agency (MHRA), London, United Kingdom 2009."},{"key":"e_1_3_5_25_1","volume-title":"United States Pharmacopeia and National Formulary (USP\u2013NF)","author":"Medicines and Healthcare products Regulatory Agency (MHRA)","year":"2015","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). United States Pharmacopeia and National Formulary (USP\u2013NF); United States Pharmacopeial Convention, Rockville, MD, USA, 2015."},{"key":"e_1_3_5_26_1","first-page":"709","article-title":"Analytical Method Development and Validation of Dapagliflozin by UV-Spectroscopy","volume":"11","author":"Tambe V. B.","year":"2012","unstructured":"Tambe, V. B.; Tajane, P. S.; Godge, R. K. Analytical Method Development and Validation of Dapagliflozin by UV-Spectroscopy. Int J Food Nutr Sci 2012, 11, 709\u2013716.","journal-title":"Int J Food Nutr Sci"},{"key":"e_1_3_5_27_1","first-page":"1569","article-title":"Development and Validation of UV Spectroscopic Method for Simultaneous Estimation of Dapagliflozin and Metformin Hydrochloride in Synthetic Mixture","volume":"4","author":"Jani B. R.","year":"2015","unstructured":"Jani, B. R.; Shah, K. V. ;P.; K. P. Development and Validation of UV Spectroscopic Method for Simultaneous Estimation of Dapagliflozin and Metformin Hydrochloride in Synthetic Mixture. Int J Res Dev Pharm Life Sci 2015, 4, 1569\u20131576.","journal-title":"Int J Res Dev Pharm Life Sci"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.5530\/phm.2017.8.16"},{"key":"e_1_3_5_29_1","first-page":"01","article-title":"Estimation of Saxagliptin Hydrochloride and Dapagliflozin Propendiol Monohydrate in Combined Dosage Form","volume":"3","author":"Asim S.","year":"2018","unstructured":"Asim, S.; Laxman, P.; Amit, J.; Jimish, P.; Mohammadali, K. Estimation of Saxagliptin Hydrochloride and Dapagliflozin Propendiol Monohydrate in Combined Dosage Form. J Innov Appl Pharm Sci 2018, 3, 01\u201307.","journal-title":"J Innov Appl Pharm Sci"},{"key":"e_1_3_5_30_1","first-page":"1102","article-title":"A Novel Method Development and Validation of Dapagliflozin and Metormin Hydrochloride Using Simultaneous Equation Method by UV\u2013 Visible Spectroscopy in Bulk and Combined Pharmaceutical Formulation Including Forced Degradation Studies","volume":"12","author":"Bhavyasri K.","year":"2020","unstructured":"Bhavyasri, K.; Surekha, T.; Sumakanth, M. A Novel Method Development and Validation of Dapagliflozin and Metormin Hydrochloride Using Simultaneous Equation Method by UV\u2013 Visible Spectroscopy in Bulk and Combined Pharmaceutical Formulation Including Forced Degradation Studies. J Pharm Sci Res 2020, 12, 1102\u20131105.","journal-title":"J Pharm Sci Res"},{"key":"e_1_3_5_31_1","first-page":"770","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Teneligliptin Hydrobromide Hydrate from Synthetic Mixture by Three Different UV Spectrophotometric Methods","volume":"11","author":"Patel A.","year":"2022","unstructured":"Patel, A.; Jadeja, P.; Mashru, R. Analytical Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Teneligliptin Hydrobromide Hydrate from Synthetic Mixture by Three Different UV Spectrophotometric Methods. World J. Pharm Res 2022, 11, 770\u2013783.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_32_1","first-page":"718","article-title":"Analytical Method Development and Validation of Sitagliptin and Dapagliflozin by Simultaneous UV Spectrophotometric Method","volume":"10","author":"Vibhute R.","year":"2023","unstructured":"Vibhute, R.; Tamboli, A.; Pingale, M.; Narale, D. Analytical Method Development and Validation of Sitagliptin and Dapagliflozin by Simultaneous UV Spectrophotometric Method. Int J Res Anal Rev 2023, 10, 718\u2013730.","journal-title":"Int J Res Anal Rev"},{"key":"e_1_3_5_33_1","first-page":"1","article-title":"Estimation Method for Dapagliflozin in Bulk and Marketed Dosage Form: Development and Validation by UV-Spectroscopy","volume":"13","author":"Saipranavi V.","year":"2023","unstructured":"Saipranavi, V.; Vaishnavi, P.; Saipriya, N.; Sowmaya, B.; Neelima, K. Estimation Method for Dapagliflozin in Bulk and Marketed Dosage Form: Development and Validation by UV-Spectroscopy. Int J Pharm Phytopharmacol Res 2023, 13, 1\u20136.","journal-title":"Int J Pharm Phytopharmacol Res"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.24092\/crps.2023.130404"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.21275\/SR24828184902"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.33472\/AFJBS.6.9.2024.1024-1032"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2024.v17i4.49083"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.7324\/japs.2016.60924"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/22297928.2017.1364664"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.18231\/2394-2797.2017.0014"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr20187-11569"},{"key":"e_1_3_5_42_1","first-page":"301","article-title":"Development and Validation of Dual Wavelength UV Spectrophotometric Method for Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Combined Dosage Form","volume":"9","author":"Jasmina S.","year":"2018","unstructured":"Jasmina, S.; Patel, B. Development and Validation of Dual Wavelength UV Spectrophotometric Method for Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Combined Dosage Form. Int J Pharm Sci 2018, 9, 301\u2013306.","journal-title":"Int J Pharm Sci"},{"key":"e_1_3_5_43_1","first-page":"3146","article-title":"RP-HPLC and UV-Spectrophotometric Methods Development and Validation for Simultaneous Estimation of Teneligliptin and Metformin in Fixed Dose Combination","volume":"9","author":"Anuruddha C.","year":"2019","unstructured":"Anuruddha, C.; Pramod, S. RP-HPLC and UV-Spectrophotometric Methods Development and Validation for Simultaneous Estimation of Teneligliptin and Metformin in Fixed Dose Combination. Curr Pharm Res 2019, 9, 3146\u20133156.","journal-title":"Curr Pharm Res"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2019.00024.3"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i5.3503"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360x.2020.00055.4"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2021.00014.7"},{"key":"e_1_3_5_48_1","first-page":"160","article-title":"Simultaneous Estimation of Teneligliptin and Metformin Hydrochloride in Tablet Formulation by UV Spectrophotometric Method","volume":"6","author":"Solanki M. S.","year":"2021","unstructured":"Solanki, M. S.; Goyal, P. K. Simultaneous Estimation of Teneligliptin and Metformin Hydrochloride in Tablet Formulation by UV Spectrophotometric Method. Chem Res J 2021, 6, 160\u2013165.","journal-title":"Chem Res J"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr20217-20784"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.35629\/5252-030738693871"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.52711\/2231-5675.2021.00034"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.24759.09127"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.47070\/ijraps.v5i9.120"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00745-8"},{"key":"e_1_3_5_55_1","first-page":"1","article-title":"UV Spectrophotometric Method Development and Validation of Teneligliptin Hydrobromide Hydrate in Bulk and Marketed Brand and Generic Tablet Dosage Form","volume":"14","author":"Alameen R.","year":"2024","unstructured":"Alameen, R.; Amirtha, R.; Anand, S.; Santhi, N.; Rajendar, S. UV Spectrophotometric Method Development and Validation of Teneligliptin Hydrobromide Hydrate in Bulk and Marketed Brand and Generic Tablet Dosage Form. Asian J Pharm Anal 2024, 14, 1\u201319.","journal-title":"Asian J Pharm Anal"},{"key":"e_1_3_5_56_1","first-page":"1","article-title":"Novel UV Spectrophotometric Approaches for the Concurrent Determination of Teneligliptin and Metformin in Tablet Formulation","volume":"17","author":"Ashim S.","year":"2024","unstructured":"Ashim, S.; Dhanya, S.; Aarti, Z.; Dilip, K.; Greeshma, P.; Jenish, A.; Rajesh, M. Novel UV Spectrophotometric Approaches for the Concurrent Determination of Teneligliptin and Metformin in Tablet Formulation. Res J Pharm Tech 2024, 17, 1\u20138.","journal-title":"Res J Pharm Tech"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.13005\/ojc\/400615"},{"key":"e_1_3_5_58_1","first-page":"905","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Glibenclamide and Metformin HCl in Bulk and Tablets Using UV-Visible Spectroscopy","volume":"1","author":"Sudarshan P.","year":"2009","unstructured":"Sudarshan, P.; Bonde, C. Development and Validation of Analytical Method for Simultaneous Estimation of Glibenclamide and Metformin HCl in Bulk and Tablets Using UV-Visible Spectroscopy. Int J ChemTech Res 2009, 1, 905\u2013909.","journal-title":"Int J ChemTech Res"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.51947"},{"key":"e_1_3_5_60_1","first-page":"3170","article-title":"Development and Validation of UV Spectroscopic Method for the Determination of Metformin Hydrochloride in Tablet Dosage Form","volume":"3","author":"Reatul K.","year":"2012","unstructured":"Reatul, K.; Banoo, N. Development and Validation of UV Spectroscopic Method for the Determination of Metformin Hydrochloride in Tablet Dosage Form. Int J. Pharm Sci Res 2012, 3, 3170.","journal-title":"Int J. Pharm Sci Res"},{"key":"e_1_3_5_61_1","first-page":"19","article-title":"Development and Validation of UV-VIS Specctroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Active Pharmaceutical Ingrident","volume":"3","author":"Narendra N.","year":"2012","unstructured":"Narendra, N.; Samy, J. G. Development and Validation of UV-VIS Specctroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Active Pharmaceutical Ingrident. J Pharm Educ Res 2012, 3, 19.","journal-title":"J Pharm Educ Res"},{"key":"e_1_3_5_62_1","first-page":"1257","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Glibenclamide and Metformin HCL in Bulk and Tablets Using UV\u2013Visible Spectroscopy","volume":"4","author":"Chavhan B. R.","year":"2015","unstructured":"Chavhan, B. R.; Patil, P.; Bavaskar, S.; Barhate, S. Development and Validation of Analytical Method for Simultaneous Estimation of Glibenclamide and Metformin HCL in Bulk and Tablets Using UV\u2013Visible Spectroscopy. World J. Pharm Res 2015, 4, 1257\u20131266.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.51.4s.109"},{"key":"e_1_3_5_64_1","first-page":"31","article-title":"Development and Validation of UV-Visible Spectroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Tablet Dosage Form","volume":"3","author":"Pravin C.","year":"2018","unstructured":"Pravin, C.; Mrunal, S.; Yogita, T.; Aditee, K.; Rutuja, L. Development and Validation of UV-Visible Spectroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Tablet Dosage Form. Int J Res Pharm Pharm Sci 2018, 3, 31\u201334.","journal-title":"Int J Res Pharm Pharm Sci"},{"key":"e_1_3_5_65_1","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4067\/s0717-97072020000204895","article-title":"Development, Computational Studies and Validation of Spectrophotometric Method of Metformin Hydrochloride in Pharmaceutical Formulations","volume":"65","author":"Ahmed J.","year":"2020","unstructured":"Ahmed, J.; Abdulla, S.; Yunusa, U.; Omar, A.; Manirul, H. Development, Computational Studies and Validation of Spectrophotometric Method of Metformin Hydrochloride in Pharmaceutical Formulations. J. Chil Chem Soc 2020, 65, 4895\u20134899.","journal-title":"J. Chil Chem Soc"},{"key":"e_1_3_5_66_1","first-page":"1","article-title":"Spectrophotometric Method Development and Validation for Simultaneous Estimation of Anagliptin and Metformin HCl BY Q-Absorption Ratio Method in Synthetic Mixture","volume":"6","author":"Ruchi M.","year":"2020","unstructured":"Ruchi, M.; Akruti, K.; Vaibhav, P. Spectrophotometric Method Development and Validation for Simultaneous Estimation of Anagliptin and Metformin HCl BY Q-Absorption Ratio Method in Synthetic Mixture. Heliyon 2020, 6, 1\u20137.","journal-title":"Heliyon"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.13040\/ijpsr.0975-8232.11(5).2173-80"},{"key":"e_1_3_5_68_1","first-page":"428","article-title":"Method Development, Validation, and Concentration Determination of Metformin Hydrochloride and Atorvastatin Calcium Using UV-Visible Spectrophotometry","volume":"12","author":"Jayasundara U.","year":"2021","unstructured":"Jayasundara, U.; Herath, H.; Kaushalya, P. Method Development, Validation, and Concentration Determination of Metformin Hydrochloride and Atorvastatin Calcium Using UV-Visible Spectrophotometry. J Anal Bioanal Tech 2021, 12, 428.","journal-title":"J Anal Bioanal Tech"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxmate.2025.101239"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-025-01565-4"},{"key":"e_1_3_5_71_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/analytica6010010","article-title":"Green Analytical Chemistry\u2014Recent Innovations","volume":"6","author":"Anil M.","year":"2025","unstructured":"Anil, M.; Akli, Z. Green Analytical Chemistry\u2014Recent Innovations. Analytica 2025, 6, 10.","journal-title":"Analytica"},{"key":"e_1_3_5_72_1","first-page":"171","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Gemigliptin and Dapagliflozin in Synthetic Mixture","volume":"8","author":"Bhoi A.","year":"2023","unstructured":"Bhoi, A.; Dalwadi, M.; Upadhyay, U. Development and Validation of Analytical Method for Simultaneous Estimation of Gemigliptin and Dapagliflozin in Synthetic Mixture. Int J Novel Res Dev 2023, 8, 171\u2013186.","journal-title":"Int J Novel Res Dev"},{"key":"e_1_3_5_73_1","first-page":"174","article-title":"Development and Validation for New Analytical Method of Dapagliflozin by RP-HPLC","volume":"15","author":"Chaudhary A.","year":"2025","unstructured":"Chaudhary, A.; Saini, R.; Patil, S. Development and Validation for New Analytical Method of Dapagliflozin by RP-HPLC. J. Pharm Anal 2025, 15, 174\u2013185.","journal-title":"J. Pharm Anal"},{"key":"e_1_3_5_74_1","unstructured":"Atul T. H.; Narendra D. Development and Validation of Dissolution Test Method for Dapagliflozin Using RP-HPLC and UV Spectrophotometer. Int J Pharm Res Sch. 2020 9 1\u201312."},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.48175\/ijarsct-19327"},{"key":"e_1_3_5_76_1","first-page":"1006","article-title":"Analytical Method Development, Validation and Forced Degradation of Dapaglipflozin by RP-HPLC","volume":"9","author":"Vaishali B.","year":"2020","unstructured":"Vaishali, B.; Charushila, B. Analytical Method Development, Validation and Forced Degradation of Dapaglipflozin by RP-HPLC\u2009. World J. Pharm Res\u2009 2020, 9, 1006\u20131076.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_77_1","first-page":"1006","article-title":"Analytical Method Development, Validation and Forced Degradation of Dapaglipflozin by RP-HPLC","volume":"9","author":"Vaishali B.","year":"2020","unstructured":"Vaishali, B.; Charushila, B. Analytical Method Development, Validation and Forced Degradation of Dapaglipflozin by RP-HPLC. World J. Pharm Res 2020, 9, 1006\u20131076.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.10(6).2688-92"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.51847\/Czxl0wYrYr"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2019.v12i3.30853"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpps202411-28629"},{"key":"e_1_3_5_82_1","first-page":"4273","article-title":"Development and Validation of RP-HPLC Method for Estimation of Dapagliflozin and Spironolactone in Synthetic Mixture","volume":"53","author":"Ketul G.","year":"2024","unstructured":"Ketul, G.; Neha, T.; Pragnesh, P. Development and Validation of RP-HPLC Method for Estimation of Dapagliflozin and Spironolactone in Synthetic Mixture. Cuest Fisioter 2024, 53, 4273\u20134306.","journal-title":"Cuest Fisioter"},{"key":"e_1_3_5_83_1","first-page":"159","article-title":"Stability-Indicating RP-HPLC Method Development for Simultaneous Determination and Estimation of Dapagliflozin in Raw and Tablet Formulation","volume":"3","author":"Manoharan G.","year":"2018","unstructured":"Manoharan, G.; Ismaiel, A.; Mohammed, Z. Stability-Indicating RP-HPLC Method Development for Simultaneous Determination and Estimation of Dapagliflozin in Raw and Tablet Formulation. Chem Res J 2018, 3, 159\u2013164.","journal-title":"Chem Res J"},{"key":"e_1_3_5_84_1","doi-asserted-by":"crossref","first-page":"e18129","DOI":"10.1590\/s2175-97902019000218129","article-title":"Application of Quality by Design Approach in RP-HPLC Method Development for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Tablet Dosage Form","volume":"55","author":"Aruna G.","year":"2019","unstructured":"Aruna, G.; Prasad, K.; Bharathi, K. Application of Quality by Design Approach in RP-HPLC Method Development for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Tablet Dosage Form. Braz J Pharm Sci 2019, 55, e18129.","journal-title":"Braz J Pharm Sci"},{"key":"e_1_3_5_85_1","first-page":"2861","article-title":"A Novel Analytical Method for Simultaneous Quantification of Dapagliflozin and Sitagliptin by Reverse Phase High Performance Liquid Chromatography","volume":"10","author":"Ajay G.","year":"2021","unstructured":"Ajay, G.; Mishra, S. K. A Novel Analytical Method for Simultaneous Quantification of Dapagliflozin and Sitagliptin by Reverse Phase High Performance Liquid Chromatography. Med Pharma All Sci 2021, 10, 2861\u20132865.","journal-title":"Med Pharma All Sci"},{"key":"e_1_3_5_86_1","first-page":"107","article-title":"Analytical Method Development and Validation for the Simultaneous Estimation of Dapagliflozin and Metformin HCL in Pure and Pharmaceutical Dosage Form","volume":"31","author":"Hariharan C.","year":"2025","unstructured":"Hariharan, C.; Dinesh Kumar, T.; Sivakumar, G.; Jagadeswaran, C.; Kamalakannan, D.; Manivannan, R. Analytical Method Development and Validation for the Simultaneous Estimation of Dapagliflozin and Metformin HCL in Pure and Pharmaceutical Dosage Form. Int J Pharm Pharm Res 2025, 31, 107\u2013116.","journal-title":"Int J Pharm Pharm Res"},{"key":"e_1_3_5_87_1","first-page":"309","article-title":"Eco-Friendly HPLC Method for Quantification of Metformin and Dapagliflozin in Tablets Dosage Form and Spiked Human Plasma Utilizing Solid Phase Extraction","volume":"67","author":"Ftaah H.","year":"2024","unstructured":"Ftaah, H.; Mahmoud, A.; Rehab, M.; El-Kaseem, M. Eco-Friendly HPLC Method for Quantification of Metformin and Dapagliflozin in Tablets Dosage Form and Spiked Human Plasma Utilizing Solid Phase Extraction. Egypt J. Chem 2024, 67, 309\u2013317.","journal-title":"Egypt J. Chem"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.18596\/jotcsa.1288000"},{"key":"e_1_3_5_89_1","first-page":"267","article-title":"A Novel HPLC Method for the Simultaneous Determination of Empagliflozin and Dapagliflozin: Development, Validation, Robustness Testing and Greenness Assessment","volume":"74","author":"Eleftheria K.","year":"2024","unstructured":"Eleftheria, K.; Maria, Z.; Yannis, D. A Novel HPLC Method for the Simultaneous Determination of Empagliflozin and Dapagliflozin: Development, Validation, Robustness Testing and Greenness Assessment. Arch Pharm 2024, 74, 267\u2013280.","journal-title":"Arch Pharm"},{"key":"e_1_3_5_90_1","first-page":"72","article-title":"Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Metformin, Saxagliptin, and Dapagliflozin","volume":"15","author":"Pavani K. H.","year":"2022","unstructured":"Pavani, K. H.; Dannana, S. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Metformin, Saxagliptin, and Dapagliflozin. Asian J. Pharm Clin Res 2022, 15, 72\u201377.","journal-title":"Asian J. Pharm Clin Res"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2025.100249"},{"key":"e_1_3_5_92_1","first-page":"189","article-title":"Development of Validated Stability Indicating Assay Method for Simultaneous Estimation of Metformin and Dapagliflozin by RP-HPLC","volume":"9","author":"Deepan T.","year":"2017","unstructured":"Deepan, T.; Rao, M. B.; Dhanaraju, M. D. Development of Validated Stability Indicating Assay Method for Simultaneous Estimation of Metformin and Dapagliflozin by RP-HPLC. Eur J Appl Sci 2017, 9, 189\u2013199.","journal-title":"Eur J Appl Sci"},{"key":"e_1_3_5_93_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/cipms-2018-0009","article-title":"Stability Indicating HPLC Method for the Simultaneous Determination of Dapagliflozin and Saxagliptin in Bulk and Tablet Dosage Form","volume":"31","author":"Thiyagarajan D.","year":"2018","unstructured":"Thiyagarajan, D.; Dasaratha, D. M. Stability Indicating HPLC Method for the Simultaneous Determination of Dapagliflozin and Saxagliptin in Bulk and Tablet Dosage Form. Curr Issues PharmMed Sci 2018, 31, 39\u201343.","journal-title":"Curr Issues PharmMed Sci"},{"key":"e_1_3_5_94_1","first-page":"9903","article-title":"Analytical Method Development and Validation of Antidiabatic Drugs Dapagliflozin Propanediol Monohydrate and Gliclazide","volume":"6","author":"Shah C.","year":"2025","unstructured":"Shah, C.; Makwana, M. Analytical Method Development and Validation of Antidiabatic Drugs Dapagliflozin Propanediol Monohydrate and Gliclazide. Int J Res Publ Rev 2025, 6, 9903\u20139910.","journal-title":"Int J Res Publ Rev"},{"key":"e_1_3_5_95_1","first-page":"242","article-title":"RP-HPLC Method for Estimation of Dapagliflozin from Its","volume":"11","author":"Mante G. V.","year":"2018","unstructured":"Mante, G. V.; Hemke, A. T. RP-HPLC Method for Estimation of Dapagliflozin from Its. Tablet Int J ChemTech Res 2018, 11, 242\u2013248.","journal-title":"Tablet Int J ChemTech Res"},{"key":"e_1_3_5_96_1","first-page":"221","article-title":"RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Formulation","volume":"2","author":"Jeyabaskaran M.","year":"2013","unstructured":"Jeyabaskaran, M.; Rambabu, C. RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Formulation. Int J Pharm Anal Res. 2013, 2, 221\u2013226.","journal-title":"Int J Pharm Anal Res"},{"key":"e_1_3_5_97_1","first-page":"48","article-title":"A New RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Dosage Form","volume":"9","author":"Debata J.","year":"2017","unstructured":"Debata, J.; Kumar, S. A New RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Dosage Form. Int J Drug Dev Res 2017, 9, 48\u201351.","journal-title":"Int J Drug Dev Res"},{"key":"e_1_3_5_98_1","first-page":"16","article-title":"Development and Validation of a New HPLC Method for the Simultaneous Estimation of Saxagliptine and Dapagliflozin and Its Application in Pharmacokinetic Studies","volume":"1","author":"Vinutha K.","year":"2018","unstructured":"Vinutha, K.; Chowdary, K.; Prasad, S. Development and Validation of a New HPLC Method for the Simultaneous Estimation of Saxagliptine and Dapagliflozin and Its Application in Pharmacokinetic Studies. Int Res J Pharm Med Sci 2018, 1, 16\u201324.","journal-title":"Int Res J Pharm Med Sci"},{"key":"e_1_3_5_99_1","first-page":"28","article-title":"Analytical Method Development and Validation for the Simultaneous Estimation of Dapagliflozin and Vildagliptin by Using RP-HPLC","volume":"12","author":"Rasapelly K. R.","year":"2024","unstructured":"Rasapelly, K. R.; Gayatri, B.; Aishwarya, B.; Shivasree, C.; Thriveni, D. Analytical Method Development and Validation for the Simultaneous Estimation of Dapagliflozin and Vildagliptin by Using RP-HPLC. World J Pharm Sci 2024, 12, 28\u201337.","journal-title":"World J Pharm Sci"},{"key":"e_1_3_5_100_1","first-page":"15","article-title":"RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Dapagliflozin in Bulk and Pharmaceutical Dosage Form","volume":"1","author":"Shraddha M.","year":"2024","unstructured":"Shraddha, M.; Ganesh, G.; Mallinath, K. RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Dapagliflozin in Bulk and Pharmaceutical Dosage Form. Res Square 2024, 1, 15.","journal-title":"Res Square"},{"key":"e_1_3_5_101_1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.21276\/irjps.2018.5.1.13","article-title":"Analytical Method Development and Statistical Validation of Dapagliflozin in Tablet Dosage Form and Bulk Drug","volume":"5","author":"Asmita M.","year":"2018","unstructured":"Asmita, M.; Chandanam, S.; Srinivas, T. R.; Akkamma, H. G.; Arpitha, S.; Thakur, K. P. Analytical Method Development and Statistical Validation of Dapagliflozin in Tablet Dosage Form and Bulk Drug. Indian Res J Pharm Sci 2018, 5, 1344\u20131356.","journal-title":"Indian Res J Pharm Sci"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.12801306"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2017v9i5.19185"},{"key":"e_1_3_5_104_1","first-page":"231","article-title":"Simple Quantified and Validated Stability Indicating Stress Degradation Studies of Oral anti-Diabetic Agent Dapagliflozin by RP-HPLC Method","volume":"14","author":"Arulselvan M.","year":"2022","unstructured":"Arulselvan, M.; Mukthinuthalapati, A. Simple Quantified and Validated Stability Indicating Stress Degradation Studies of Oral anti-Diabetic Agent Dapagliflozin by RP-HPLC Method. Int J Appl Pharmaceut 2022, 14, 231\u2013237.","journal-title":"Int J Appl Pharmaceut"},{"key":"e_1_3_5_105_1","first-page":"109","article-title":"Stability Indicating HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Metformin Tablet Dosage Form","volume":"15","author":"Dhanshri N.","year":"2022","unstructured":"Dhanshri, N.; Aejaz, A.; Khan, G. J. Stability Indicating HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Metformin Tablet Dosage Form. Asian J. Pharm Clin Res 2022, 15, 109\u2013114.","journal-title":"Asian J. Pharm Clin Res"},{"key":"e_1_3_5_106_1","first-page":"923","article-title":"Analytical Method Development and Validation of Dapagliflozin and Linagliptin Tablets by RP-HPLC","volume":"22","author":"Sowmya S.","year":"2023","unstructured":"Sowmya, S.; Krishna, S. Analytical Method Development and Validation of Dapagliflozin and Linagliptin Tablets by RP-HPLC. Ymer 2023, 22, 923\u2013941.","journal-title":"Ymer"},{"key":"e_1_3_5_107_1","first-page":"1156","article-title":"A New HPLC Method Development and Validation for the Determination of Dapagliflozin in Tablet Dosage Form","volume":"8","author":"Narottam P.","year":"2019","unstructured":"Narottam, P.; Tayyaba, M.; Pravalika, R.; Srinivasa, R. A New HPLC Method Development and Validation for the Determination of Dapagliflozin in Tablet Dosage Form. World J. Pharm Res 2019, 8, 1156\u20131165.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_108_1","first-page":"1799","article-title":"Analytical Methods for Simultaneous Estimation of SGLT2 Inhibitor and DPP-4 Inhibitor in Their Combination for Treatment of Type 2 Diabetes Mellitus","volume":"10","author":"Mehul P.","year":"2021","unstructured":"Mehul, P.; Vyas, N.; Shah, H.; Shah, U.; Patel, A.; Chokshi, A. Analytical Methods for Simultaneous Estimation of SGLT2 Inhibitor and DPP-4 Inhibitor in Their Combination for Treatment of Type 2 Diabetes Mellitus. Lett Appl NanoBioScience 2021, 10, 1799\u20131815.","journal-title":"Lett Appl NanoBioScience"},{"key":"e_1_3_5_109_1","first-page":"660","article-title":"Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Estimation of Dapagliflozin Propanediol and Metformin Hydrochloride in Tablet Dosage Form","volume":"2020","author":"Nikita P.","year":"2020","unstructured":"Nikita, P.; Bhavesh, P. Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Estimation of Dapagliflozin Propanediol and Metformin Hydrochloride in Tablet Dosage Form. Int J Pharm Sci Drug Res 2020, 2020, 660\u2013667.","journal-title":"Int J Pharm Sci Drug Res"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.53730\/ijhs.v6nS4.10505"},{"key":"e_1_3_5_111_1","first-page":"143","article-title":"Analytical Method Development and Validation of Sitagliptin and Dapagliflozin by RP-HPLC","volume":"10","author":"Vibhute R.","year":"2025","unstructured":"Vibhute, R.; Sayyad, K. Analytical Method Development and Validation of Sitagliptin and Dapagliflozin by RP-HPLC. Int J Sci Dev Res 2025, 10, 143\u2013156.","journal-title":"Int J Sci Dev Res"},{"key":"e_1_3_5_112_1","first-page":"254","article-title":"RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Saxagliptin in Bulk Samples","volume":"11","author":"Rama R.","year":"2019","unstructured":"Rama, R.; Venkata, R.; Venkateswarlu, B. S. RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Saxagliptin in Bulk Samples. J Pharm Sci Res 2019, 11, 254\u2013257.","journal-title":"J Pharm Sci Res"},{"key":"e_1_3_5_113_1","first-page":"86","article-title":"Validation of Stability-Indicating Reverse Phase HPLC Method for the Determination of Related Substances in Dapagliflozin Drug Substance","volume":"12","author":"Goutam S.","year":"2017","unstructured":"Goutam, S.; Babu, R.; Annapurna, N. A.; V.; Vundavilli, K.; Kumar, P.; Hemant, S. Validation of Stability-Indicating Reverse Phase HPLC Method for the Determination of Related Substances in Dapagliflozin Drug Substance. IOSR J Pharm Biol Sci 2017, 12, 86\u201394.","journal-title":"IOSR J Pharm Biol Sci"},{"key":"e_1_3_5_114_1","first-page":"1","article-title":"Simultaneous Estimation of Dapagliflozin and Linagliptin Using Reverse phase-HPLC with Photo Diode Array (PDA)","volume":"18","author":"Anchal S.","year":"2024","unstructured":"Anchal, S.; Usmangani, C.; Dimal, S.; Jinal, T.; Heta, K.; Mital, P. Simultaneous Estimation of Dapagliflozin and Linagliptin Using Reverse phase-HPLC with Photo Diode Array (PDA). J. Chem Metrol 2024, 18, 1\u201314.","journal-title":"J. Chem Metrol"},{"key":"e_1_3_5_115_1","first-page":"13","article-title":"A New Analytical Method Development and Validation for the Estimation of Dapagliflozin by Using Reverse Phase-High Performance Liquid Chromatography","volume":"6","author":"Sravanthi S.","year":"2021","unstructured":"Sravanthi, S.; Neha, Z.; Shruthi, B.; Ramya, K.; Manjeera, A. A New Analytical Method Development and Validation for the Estimation of Dapagliflozin by Using Reverse Phase-High Performance Liquid Chromatography. Int J Adv Res Med Pharm Sci 2021, 6, 13\u201320.","journal-title":"Int J Adv Res Med Pharm Sci"},{"key":"e_1_3_5_116_1","first-page":"70","article-title":"Estimation of Dapagliflozin in Pure and Marketed Formulation by Validated Reverse Phase-High Performance Liquid Chromatographic Method","volume":"10","author":"Sree V.","year":"2020","unstructured":"Sree, V.; Bhavyasri, K.; Sumakanth, M.; Swethasri, R. Estimation of Dapagliflozin in Pure and Marketed Formulation by Validated Reverse Phase-High Performance Liquid Chromatographic Method. Int J Life Sci Pharma Res 2020, 10, 70\u201384.","journal-title":"Int J Life Sci Pharma Res"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.21276\/ijprhs.2017.04.07"},{"key":"e_1_3_5_118_1","first-page":"560","article-title":"Development of a Validated Highly Sensitive and Eco Friendly Approach for the Simultaneous Determination of Dapagliflozin and Gliclazide in Bulk and Tablet Formulation by RP-HPLC Method","volume":"23","author":"Suganthi A.","year":"2024","unstructured":"Suganthi, A.; Syed, I.; Ravi, T. K. Development of a Validated Highly Sensitive and Eco Friendly Approach for the Simultaneous Determination of Dapagliflozin and Gliclazide in Bulk and Tablet Formulation by RP-HPLC Method. Ymer 2024, 23, 560\u2013570.","journal-title":"Ymer"},{"key":"e_1_3_5_119_1","first-page":"5927","article-title":"Method Development of Metformin, Saxagliptin and Dapagliflozin in Marketed Formulation by HPLC","volume":"6","author":"Suman S. S.","year":"2022","unstructured":"Suman, S. S.; Chaubey, R. Method Development of Metformin, Saxagliptin and Dapagliflozin in Marketed Formulation by HPLC. Int J Health Sci 2022, 6, 5927\u20135936.","journal-title":"Int J Health Sci"},{"key":"e_1_3_5_120_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s43094-023-00556-3","article-title":"Development of Novel Gradient RP-HPLC Method for Separation of Dapagliflozin and Its Process-Related Impurities: Insight into Stability Profile and Degradation Pathway, Identification of Degradants Using LCMS","volume":"9","author":"Bhawani S.","year":"2023","unstructured":"Bhawani, S.; Venkata, T. N.; Kumar, G. Development of Novel Gradient RP-HPLC Method for Separation of Dapagliflozin and Its Process-Related Impurities: Insight into Stability Profile and Degradation Pathway, Identification of Degradants Using LCMS. Future J Pharm Sci 2023, 9, 107.","journal-title":"Future J Pharm Sci"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.31032\/ijbpas\/2023\/12.10.7377"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00734-x"},{"key":"e_1_3_5_123_1","first-page":"2139","article-title":"Development and Validation of RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Metformin in Bulk and in Synthetic Mixture","volume":"6","author":"Afshan U.","year":"2017","unstructured":"Afshan, U.; Shyam, S.; Vasanthi, R.; Alagar, R.; Rajeswar, D.; Rao, K.; Ramana, H. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Metformin in Bulk and in Synthetic Mixture. World J Pharm Pharmaceutic Sci 2017, 6, 2139\u20132150.","journal-title":"World J Pharm Pharmaceutic Sci"},{"key":"e_1_3_5_124_1","first-page":"499","article-title":"Stability Indicating RP-HPLC Method for Determination of Saxagliptin and Dapagliflozin in Bulk and Tablet Dosage Forms","volume":"12","author":"Usman M.","year":"2020","unstructured":"Usman, M.; Sufiyan, A.; Chandrakant, D.; Tanvir, S.; Bharat, J.; Imran, M. Stability Indicating RP-HPLC Method for Determination of Saxagliptin and Dapagliflozin in Bulk and Tablet Dosage Forms. J Pharmaceut Sci Res 2020, 12, 499\u2013506.","journal-title":"J Pharmaceut Sci Res"},{"key":"e_1_3_5_125_1","first-page":"206","article-title":"Development and Validation of Stability Indicating Estimation Method of Dapagliflozin in It\u2019s Tablet Dosage Form","volume":"6","author":"Yavantika V.","year":"2019","unstructured":"Yavantika, V.; Pragnesh, P.; Digesh, P. Development and Validation of Stability Indicating Estimation Method of Dapagliflozin in It\u2019s Tablet Dosage Form. Int J Res Anal Rev 2019, 6, 206\u2013213.","journal-title":"Int J Res Anal Rev"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.13040\/ijpsr.0975-8232.14(2).788-94"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1556\/1326.2024.01226"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.113357"},{"key":"e_1_3_5_129_1","first-page":"477","article-title":"Stability Indicating Ultrafast Liquid Chromatographic Method for the Estimation of Teneligliptin (an anti-Diabetic Agent)","volume":"12","author":"Mukthinuthalapati A. M.","year":"2018","unstructured":"Mukthinuthalapati, A. M.; Sara, A.; Rajeshree, B.; Narendra, A. Stability Indicating Ultrafast Liquid Chromatographic Method for the Estimation of Teneligliptin (an anti-Diabetic Agent). Asian J Pharm 2018, 12, 477\u2013483.","journal-title":"Asian J Pharm"},{"key":"e_1_3_5_130_1","first-page":"37","article-title":"Analytical Method Development and Validation of Teneligliptin Hydrobromide in Pure Form by HPLC","volume":"5","author":"Ashwini B.","year":"2017","unstructured":"Ashwini, B.; Nitin, D.; Ashwini, S.; Vishnu, S. Analytical Method Development and Validation of Teneligliptin Hydrobromide in Pure Form by HPLC. World J Pharm Sci 2017, 5, 37\u201349.","journal-title":"World J Pharm Sci"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2020.00003.4"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360x.2020.00320.0"},{"key":"e_1_3_5_133_1","first-page":"1","article-title":"Development and Validation of Stability Indicating RP-HPLC Method for Teneligliptin Hydrobromide Hydrate","volume":"11","author":"Girish D.","year":"2021","unstructured":"Girish, D.; Bobade, G. Development and Validation of Stability Indicating RP-HPLC Method for Teneligliptin Hydrobromide Hydrate. American J Pharmatech Res 2021, 11, 1\u201312.","journal-title":"American J Pharmatech Res"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.15515\/abr.0976-4585.15.5.150156"},{"key":"e_1_3_5_135_1","first-page":"2","article-title":"Development and Validation Of RP-HPLC Method For Simultaneous Estimation of Rosuvastatin and Teneligliptin in Their Synthetic Mixture","volume":"60","author":"Minakshi D.","year":"2023","unstructured":"Minakshi, D.; Maitri, P.; Krunal, K.; Pathik, J. Development and Validation Of RP-HPLC Method For Simultaneous Estimation of Rosuvastatin and Teneligliptin in Their Synthetic Mixture. Ebsco 2023, 60, 2.","journal-title":"Ebsco"},{"key":"e_1_3_5_136_1","first-page":"935","article-title":"Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Its Dosage Form Using RP-HPLC","volume":"7","author":"Kaneez F.","year":"2017","unstructured":"Kaneez, F.; Vani, R.; Sunathi, M. Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Its Dosage Form Using RP-HPLC. Indo Am J Pharm Res 2017, 7, 935\u2013945.","journal-title":"Indo Am J Pharm Res"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.9734\/ajacr\/2018\/v1i49701"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijpi.14.2.70"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.54037\/WJPS.2022.100905"},{"key":"e_1_3_5_140_1","first-page":"740","article-title":"Analytical Method Development and Validation Studies of Anti Diabetic Drugs by HPLC","volume":"9","author":"Pallavi H.","year":"2021","unstructured":"Pallavi, H.; Raman, C. Analytical Method Development and Validation Studies of Anti Diabetic Drugs by HPLC. Int J Creat Res Thoughts 2021, 9, 740\u2013745.","journal-title":"Int J Creat Res Thoughts"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360x.2023.00025"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.29228\/jrp.848"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijpi.14.2.69"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40543-016-0107-4"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.31838\/ijpr\/2021.13.03.061"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c04589"},{"key":"e_1_3_5_147_1","first-page":"736","article-title":"Simultaneous Determination of Metformin and Teneligliptin by Liquid Chromatography in Tablets","volume":"12","author":"Mrunal C. S.","year":"2018","unstructured":"Mrunal, C. S.; Mathrusri, A. M. Simultaneous Determination of Metformin and Teneligliptin by Liquid Chromatography in Tablets. Asian J Pharm 2018, 12, 736\u2013739.","journal-title":"Asian J Pharm"},{"key":"e_1_3_5_148_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/22297928.2022.2131467","article-title":"Stability Indicating RP-HPLC-DAD Method for Simultaneous Estimation of Atorvaststin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture","volume":"12","author":"Urvi C.","year":"2022","unstructured":"Urvi, C.; Hiteksha, D.; Disha, B.; Amitkumar, V.; Dhruvanshi, G. Stability Indicating RP-HPLC-DAD Method for Simultaneous Estimation of Atorvaststin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture. Anal Chem Lett 2022, 12, 629\u2013639.","journal-title":"Anal Chem Lett"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.53879\/id.56.08.11253"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00769-024-01625-7"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.31142\/ijtsrd21735"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmad061"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr201710-9225"},{"key":"e_1_3_5_154_1","first-page":"420","article-title":"Developmentand Validation of RP-HPLC Methodfor Simultaneous Estimation of Teneligliptin Hemipentahydrobromide Hydrate and Metformin Hydrochloridein Their Combined Tablet Dosage Form","volume":"8","author":"Pandya R.","year":"2017","unstructured":"Pandya, R.; Sakheliya, B.; Patani, P. Developmentand Validation of RP-HPLC Methodfor Simultaneous Estimation of Teneligliptin Hemipentahydrobromide Hydrate and Metformin Hydrochloridein Their Combined Tablet Dosage Form. Pharma Sci Monit 2017, 8, 420\u2013434.","journal-title":"Pharma Sci Monit"},{"key":"e_1_3_5_155_1","first-page":"124","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Pharmaceutical Dosage Form","volume":"8","author":"Patel K. B.","year":"2017","unstructured":"Patel, K. B.; Joshi, H. V.; Shah, U. A.; Patel, J. K. Development and Validation of Analytical Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Pharmaceutical Dosage Form. Int J Pharm Sci 2017, 8, 124\u2013136.","journal-title":"Int J Pharm Sci"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360x.2023.00084"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.5267\/j.ccl.2021.4.001"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.47583\/ijpsrr.2021.v69i02.019"},{"key":"e_1_3_5_159_1","first-page":"5670","article-title":"Validated Isocratic Liquid Chromatographic Method for the Quantification of Teneligliptin in the Presence of Internal Standard","volume":"12","author":"Rajesh P.","year":"2018","unstructured":"Rajesh, P.; Mathrusri, A. M. Validated Isocratic Liquid Chromatographic Method for the Quantification of Teneligliptin in the Presence of Internal Standard. Int J Green Pharm 2018, 12, 5670\u20135674.","journal-title":"Int J Green Pharm"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412917999201102204804"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2017v9i12.21151"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.46624\/ajptr.2021.v11.i3.004"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr20178-8977"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.galenos.2018.16768"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.22270\/ajprd.v12i6.1456"},{"key":"e_1_3_5_166_1","first-page":"4325","article-title":"RP-HPLC Method Development and Validation for Simultaneous Estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture","volume":"17","author":"Amitkumar V.","year":"2024","unstructured":"Amitkumar, V.; Harshal, V.; Jayshree, G.; Chirag, J.; Aajay, P.; Ashok, P.; Ashvin, D. RP-HPLC Method Development and Validation for Simultaneous Estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture. Res J Pharm Tech 2024, 17, 4325\u20134328.","journal-title":"Res J Pharm Tech"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202400229"},{"key":"e_1_3_5_168_1","first-page":"1858","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Pharmaceutical Dosage Form by RP-HPLC","volume":"21","author":"Reddy R.","year":"2022","unstructured":"Reddy, R.; Lavanya, J.; Rama Rao, T.; Revathi, B. Analytical Method Development and Validation for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Pharmaceutical Dosage Form by RP-HPLC. Ymer 2022, 21, 1858\u20131869.","journal-title":"Ymer"},{"key":"e_1_3_5_169_1","first-page":"40","article-title":"Analytical Method Development And Validation For Simultaneous Estimation of Metformin and Linagliptin","volume":"7","author":"Ahmed A.","year":"2019","unstructured":"Ahmed, A.; Khan, G. J.; Mustaqueem, B.; Yaasir, A.; Inamdar, Z. E. Analytical Method Development And Validation For Simultaneous Estimation of Metformin and Linagliptin. Int J Res Adv Tech 2019, 7, 40\u201344.","journal-title":"Int J Res Adv Tech"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2018.06.007"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32551"},{"key":"e_1_3_5_172_1","first-page":"148","article-title":"Development Validation and Stability Indicating of RP-HPLC Method for Estimation of Metformin and Sitagliptin in Pharmaceutical Dosage Form","volume":"18","author":"Navghare A. B.","year":"2022","unstructured":"A. B.; Navghare, Shirat, M. K.. Development Validation and Stability Indicating of RP-HPLC Method for Estimation of Metformin and Sitagliptin in Pharmaceutical Dosage Form. Int Adv. J Eng Sci Manag 2022, 18, 148\u2013152.","journal-title":"Int Adv. J Eng Sci Manag"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-023-00503-2"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00362-9"},{"key":"e_1_3_5_175_1","first-page":"135","article-title":"Development and Validation of RP-HPLC Method for Simultaneous Determination of Metformin and Miglitol in Bulk and Pharmaceutical Formulation","volume":"6","author":"Bhoomaiah B.","year":"2014","unstructured":"Bhoomaiah, B.; Jaya, S. Development and Validation of RP-HPLC Method for Simultaneous Determination of Metformin and Miglitol in Bulk and Pharmaceutical Formulation. Int J. Pharm Pharm Sci 2014, 6, 135\u2013141.","journal-title":"Int J. Pharm Pharm Sci"},{"key":"e_1_3_5_176_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5958\/2231-5675.2019.00036.X","article-title":"Development and Validation of Q-Absorbance Ratio Method for Simultaneous Estimation of Teniligliptin Hydrobromide and Metformin HCl in Multicomponent Dosage Form","volume":"9","author":"Sonali G.","year":"2019","unstructured":"Sonali, G.; Ashish, N.; Vaishali, W.; Tilottama, G.; Shrutika, Z.; Najuka, M.; Vikrant, S. Development and Validation of Q-Absorbance Ratio Method for Simultaneous Estimation of Teniligliptin Hydrobromide and Metformin HCl in Multicomponent Dosage Form. Asian J Pharm Anal 2019, 9, 215\u2013218.","journal-title":"Asian J Pharm Anal"},{"key":"e_1_3_5_177_1","first-page":"20","article-title":"A Novel RP-HPLC Method Development and Validation for the Quantification of a Potential anti-Diabetic Drug Metformin Hydrochloride in Tablet Dosage Form","volume":"14","author":"Jayashree H.","year":"2022","unstructured":"Jayashree, H.; Harish, K. A Novel RP-HPLC Method Development and Validation for the Quantification of a Potential anti-Diabetic Drug Metformin Hydrochloride in Tablet Dosage Form. Int J Curr Pharm Res 2022, 14, 20\u201324.","journal-title":"Int J Curr Pharm Res"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5384"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061187"},{"key":"e_1_3_5_180_1","first-page":"573","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Remogliflozin Etabonate, Vildagliptin and Metformin Hydrochloride in Combined Dosage Form","volume":"25","author":"Jagrutiben P.","year":"2022","unstructured":"Jagrutiben, P.; Shuchi, D. Analytical Method Development and Validation for Simultaneous Estimation of Remogliflozin Etabonate, Vildagliptin and Metformin Hydrochloride in Combined Dosage Form. Int J Pharm Pharm Res 2022, 25, 573\u2013597.","journal-title":"Int J Pharm Pharm Res"},{"key":"e_1_3_5_181_1","first-page":"50","article-title":"Novel UV-Spectrophotometric and RP-HPLC Method Development and Validation of Simultaneous Estimation of Ranolazine and Metformin HCl: A Statistical Analysis","volume":"9","author":"Jitesha P.","year":"2020","unstructured":"Jitesha, P.; Parth, P.; Rajashree, M. Novel UV-Spectrophotometric and RP-HPLC Method Development and Validation of Simultaneous Estimation of Ranolazine and Metformin HCl: A Statistical Analysis. Pharm Innov J 2020, 9, 50\u201357.","journal-title":"Pharm Innov J"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.21276\/ijpbs.2019.9.3.67"},{"key":"e_1_3_5_183_1","first-page":"516","article-title":"Analytical Method Validation of Metformin Hcl and Linagliptin Tablet by HPLC","volume":"7","author":"Neupane P.","year":"2022","unstructured":"Neupane, P.; Arya, S.; Pandey, P. Analytical Method Validation of Metformin Hcl and Linagliptin Tablet by HPLC. Int J Novel Res Dev 2022, 7, 516\u2013524.","journal-title":"Int J Novel Res Dev"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.46795\/ijhcbs.v4i1.417"},{"key":"e_1_3_5_185_1","first-page":"231","article-title":"Development and Validation of RP-HPLC Method for the Analysis of Metformin","volume":"19","author":"Saeed A.","year":"2006","unstructured":"Saeed, A.; Najma, S.; Hashim, Z. Development and Validation of RP-HPLC Method for the Analysis of Metformin. Pak J Pharm Sci 2006, 19, 231\u2013235.","journal-title":"Pak J Pharm Sci"},{"key":"e_1_3_5_186_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/separations7040059","article-title":"Development and Validation of Rapid RP-HPLC and Green Second-Derivative UV Spectroscopic Methods for Simultaneous Quantification of Metformin and Remogliflozin in Formulation Using Experimental Design","volume":"7","author":"Mahesh A.","year":"2020","unstructured":"Mahesh, A.; Elgack, E. R. E.; Rajasekaran, S.; Monirul, I. M.; Katharigatta, V.; Sreeharsha, N.; Ahmed, B. A. Development and Validation of Rapid RP-HPLC and Green Second-Derivative UV Spectroscopic Methods for Simultaneous Quantification of Metformin and Remogliflozin in Formulation Using Experimental Design. J Separations 2020, 7, 59.","journal-title":"J Separations"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1556\/AChrom.20.2008.3.11"},{"key":"e_1_3_5_188_1","first-page":"2965","article-title":"Method Development and Validation of Vildagliptin and Metformin HCL in Pharmaceutical Dosage Form by Reversed Phase-High Performance Liquid Chromatography (RP-HPLC)","volume":"9","author":"Abu D.","year":"2018","unstructured":"Abu, D.; Hamad, M.; Mallah, E.; Dayyih, A.; Awad, R.; Zakaria, Z.; Arafat, T. Method Development and Validation of Vildagliptin and Metformin HCL in Pharmaceutical Dosage Form by Reversed Phase-High Performance Liquid Chromatography (RP-HPLC). Int J. Pharm Sci Res 2018, 9, 2965\u20132972.","journal-title":"Int J. Pharm Sci Res"},{"key":"e_1_3_5_189_1","first-page":"55","article-title":"New Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Glibenclamide in Bulk and Tablet Dosage Form Using RP-HPLC","volume":"7","author":"Subhashini E.","year":"2014","unstructured":"Subhashini, E.; Syama, S. New Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Glibenclamide in Bulk and Tablet Dosage Form Using RP-HPLC. Rasayan J. Chem. 2014, 7, 55\u201363.","journal-title":"Rasayan J. Chem."},{"key":"e_1_3_5_190_1","first-page":"83","article-title":"Development and Validation of a Simple Method for Simultaneous Estimation of Metformin Hydrochloride and Gliclazide in Tablets by Using Reversed Phase High Performance Liquid Chromatography","volume":"9","author":"Kanij F.","year":"2010","unstructured":"Kanij, F.; Zakiur, R. M.; Tasnuva, H.; Kalam, A. M. A.; Selim, R. M. Development and Validation of a Simple Method for Simultaneous Estimation of Metformin Hydrochloride and Gliclazide in Tablets by Using Reversed Phase High Performance Liquid Chromatography. Dhaka Uni J Pharm Sci 2010, 9, 83\u201389.","journal-title":"Dhaka Uni J Pharm Sci"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/726235"},{"key":"e_1_3_5_192_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.22159\/ijap.2018.v10s1.26","article-title":"Development and Validation of a High-Performance Liquid Chromatography Method for Determining Metformin Hydrochloride in Dried Blood Spots","volume":"10","author":"Yahdiana H.","year":"2018","unstructured":"Yahdiana, H.; Arum, S. P.; Catur, J. Development and Validation of a High-Performance Liquid Chromatography Method for Determining Metformin Hydrochloride in Dried Blood Spots. Int J Appl Pharm 2018, 10, 126\u2013129.","journal-title":"Int J Appl Pharm"},{"key":"e_1_3_5_193_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/scipharm85030025","article-title":"Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of impurity-VII, VIII and IX and Synthesis of impurity-VII","volume":"85","author":"Sushant J.","year":"2017","unstructured":"Sushant, J.; Sunil, R.; Kalyanaraman, N.; Popatrao, B. Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of impurity-VII, VIII and IX and Synthesis of impurity-VII. Scientia Pharm 2017, 85, 25.","journal-title":"Scientia Pharm"},{"key":"e_1_3_5_194_1","first-page":"11","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Bromocriptine Mesylate and Metformin Hydrochloride with DoE Approach","volume":"4","author":"Bhayji J.","year":"2015","unstructured":"Bhayji, J.; Tandel, F.; Patel, N. Analytical Method Development and Validation for Simultaneous Estimation of Bromocriptine Mesylate and Metformin Hydrochloride with DoE Approach. World J Pharm Pharm Sci 2015, 4, 11\u201315.","journal-title":"World J Pharm Pharm Sci"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.5530\/phm.2014.1.5"},{"key":"e_1_3_5_196_1","first-page":"10","article-title":"Development and Validation of Analytical Methods for Simultaneous Estimation of Voglibose, Glimepiride and Metformin Hydrochloride in Bulk and Tablet Dosage Form by HPLC","volume":"1","author":"Kadam V. N.","year":"2014","unstructured":"Kadam, V. N.; Yadav, P. J.; Mohite, S. K.; Magdum, C. S. Development and Validation of Analytical Methods for Simultaneous Estimation of Voglibose, Glimepiride and Metformin Hydrochloride in Bulk and Tablet Dosage Form by HPLC. Int J Pharm Pharm Res 2014, 1, 10\u201321.","journal-title":"Int J Pharm Pharm Res"},{"key":"e_1_3_5_197_1","first-page":"1844","article-title":"Development and Validation of Chromatographic and Spectroscopic Methods for Estimation of Repaglinide and Metformin Hcl in Combined Dosage Form","volume":"5","author":"Manal F.","year":"2014","unstructured":"Manal, F.; Noha, R. Development and Validation of Chromatographic and Spectroscopic Methods for Estimation of Repaglinide and Metformin Hcl in Combined Dosage Form. J Global Trends Pharm Sci 2014, 5, 1844\u20131848.","journal-title":"J Global Trends Pharm Sci"},{"key":"e_1_3_5_198_1","doi-asserted-by":"publisher","DOI":"10.7897\/2230-8407.04850"},{"key":"e_1_3_5_199_1","first-page":"117","article-title":"Simple and Sensitive Analytical Method Development and Validation of Metformin Hydrochloride by RP-HPLC","volume":"3","author":"Madhukar A.","year":"2011","unstructured":"Madhukar, A.; Prince, A.; Vijay Kumar, R.; Sanjeeva, Y.; Jagadeeshwar, K.; Raghupratap, D. Simple and Sensitive Analytical Method Development and Validation of Metformin Hydrochloride by RP-HPLC. Int J. Pharm Pharm Sci 2011, 3, 117\u2013120.","journal-title":"Int J. Pharm Pharm Sci"},{"key":"e_1_3_5_200_1","first-page":"799","article-title":"Analytical Method Development and Validation of Metformin Hydrochloride by RP-HPLC in Drug Substance","volume":"7","author":"Merugu M.","year":"2017","unstructured":"Merugu, M.; Peddiboina, G. Analytical Method Development and Validation of Metformin Hydrochloride by RP-HPLC in Drug Substance. World J. Pharm Res 2017, 7, 799\u2013808.","journal-title":"World J. Pharm Res"},{"key":"e_1_3_5_201_1","first-page":"4047","article-title":"Simultaneous Determination of Metformin Hydrochloride and Linagliptin by RP-HPLC in Bulk and Pharmaceutical Formulations","volume":"4","author":"Sheena M.","year":"2014","unstructured":"Sheena, M.; Reddy, R.; Kumar, S.; Chaitanya, G.; Priyanka, E.; Hima, B. Simultaneous Determination of Metformin Hydrochloride and Linagliptin by RP-HPLC in Bulk and Pharmaceutical Formulations. Indo American J Pharm Res 2014, 4, 4047\u20134053.","journal-title":"Indo American J Pharm Res"},{"key":"e_1_3_5_202_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.56031"},{"key":"e_1_3_5_203_1","first-page":"415","article-title":"Analytical Method Development and Validation of Metformin Hydrochloride by Using RP-HPLC with ICH Guidelines","volume":"3","author":"Nilesh N.","year":"2019","unstructured":"Nilesh, N.; Avish, M.; Anil, J.; Prashant, M. Analytical Method Development and Validation of Metformin Hydrochloride by Using RP-HPLC with ICH Guidelines. Int J Trend Sci Res Dev 2019, 3, 415\u2013419.","journal-title":"Int J Trend Sci Res Dev"},{"key":"e_1_3_5_204_1","doi-asserted-by":"publisher","DOI":"10.48175\/ijarsct-11667"},{"key":"e_1_3_5_205_1","first-page":"252","article-title":"Development of a Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Rosuvastatin Calcium in Bulk and in-House Formulation","volume":"5","author":"Murthy T. G. K.","year":"2014","unstructured":"Murthy, T. G. K.; Geethanjali, J. Development of a Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Rosuvastatin Calcium in Bulk and in-House Formulation. Chromatogr Sep Tech 2014, 5, 252\u2013259.","journal-title":"Chromatogr Sep Tech"},{"key":"e_1_3_5_206_1","first-page":"121","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Metformin HCl and Sitagliptin RP-HPLC","volume":"21","author":"Mhaske N. S.","year":"2021","unstructured":"Mhaske, N. S.; Takpere, S. J. Analytical Method Development and Validation for Simultaneous Estimation of Metformin HCl and Sitagliptin RP-HPLC. Int J Pharm Pharm Res 2021, 21, 121\u2013127.","journal-title":"Int J Pharm Pharm Res"},{"key":"e_1_3_5_207_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5530\/ijper.20253781","article-title":"Stability Indicating RP-HPLC Method Development and Validation for the Simultaneous Quantification of Remogliflozin Etabonate and Metformin HCl","volume":"59","author":"Popatlal K. P.","year":"2025","unstructured":"Popatlal, K. P.; Vishwa, P. Stability Indicating RP-HPLC Method Development and Validation for the Simultaneous Quantification of Remogliflozin Etabonate and Metformin HCl. Indian J Pharm Educ Res 2025, 59, 274\u2013s282.","journal-title":"Indian J Pharm Educ Res"},{"key":"e_1_3_5_208_1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/jaoacint\/qsac025","article-title":"DoE-Based Analytical Failure Modes Critical Effect Analysis (AFMCEA) to a multipurpose-RP-HPLC Method for the Estimation of Multiple FDC Products of Metformin Hydrochloride Using an Analytical Quality by Design Approach","volume":"105","author":"Pintu P.","year":"2022","unstructured":"Pintu, P.; Krishna, M.; Shailesh, S. DoE-Based Analytical Failure Modes Critical Effect Analysis (AFMCEA) to a multipurpose-RP-HPLC Method for the Estimation of Multiple FDC Products of Metformin Hydrochloride Using an Analytical Quality by Design Approach. J. AOAC Int 2022, 105, 986\u2013998.","journal-title":"J. AOAC Int"},{"key":"e_1_3_5_209_1","doi-asserted-by":"publisher","DOI":"10.4236\/ajac.2014.511082"},{"key":"e_1_3_5_210_1","first-page":"267","article-title":"Development and Validation of RP-HPLC Method for Metformin Hydrochloride and Nateglinide in Bulk and Combined Dosage Form","volume":"8","author":"Chengalva P.","year":"2016","unstructured":"Chengalva, P.; Angala Parameswari, S.; Aruna, G. Development and Validation of RP-HPLC Method for Metformin Hydrochloride and Nateglinide in Bulk and Combined Dosage Form. Int J. Pharm Pharm Sci 2016, 8, 267\u2013271.","journal-title":"Int J. Pharm Pharm Sci"},{"key":"e_1_3_5_211_1","first-page":"113","article-title":"Analytical Method Development and Validation of Antidiabetic Drugs (Metformin and Linagliptin) in Tablet Dosage Form by Using RP-HPLC Method","volume":"5","author":"Srinivasa Rao S.","year":"2019","unstructured":"Srinivasa Rao, S.; Chandra Shekar, M.; Nagaprasanna, N.; Supriya, T. Analytical Method Development and Validation of Antidiabetic Drugs (Metformin and Linagliptin) in Tablet Dosage Form by Using RP-HPLC Method. World J Pharm Life Sci 2019, 5, 113\u2013120.","journal-title":"World J Pharm Life Sci"},{"key":"e_1_3_5_212_1","first-page":"8051","article-title":"Analytical Method Development and Validation of Teneligliptin and Metformin HCl by Using RP-HPLC Method","volume":"11","author":"Shirisha K.","year":"2020","unstructured":"Shirisha, K.; Amina Begum, K.; Sravya, K.; Swarna, K.; Neelima, K.; Srinivasa Rao, S. Analytical Method Development and Validation of Teneligliptin and Metformin HCl by Using RP-HPLC Method. J Global Trends Pharm Sci 2020, 11, 8051\u20138056.","journal-title":"J Global Trends Pharm Sci"},{"key":"e_1_3_5_213_1","doi-asserted-by":"publisher","DOI":"10.20902\/ijctr.2018.111149"},{"key":"e_1_3_5_214_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmab030"},{"key":"e_1_3_5_215_1","first-page":"13","article-title":"Development and Validation of Stability-Indicating RP-HPLC Method for Simultaneous Determination of Metformin HCI and Glimepiride in Fixed-Dose Combination","volume":"11","author":"Pradnya V.","year":"2016","unstructured":"Pradnya, V.; Purnima, A. Development and Validation of Stability-Indicating RP-HPLC Method for Simultaneous Determination of Metformin HCI and Glimepiride in Fixed-Dose Combination. Anal Chem Insights 2016, 11, 13\u201320.","journal-title":"Anal Chem Insights"},{"key":"e_1_3_5_216_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70013"},{"key":"e_1_3_5_217_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18121778"},{"key":"e_1_3_5_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2018.08.137"},{"key":"e_1_3_5_219_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-024-00002-0"},{"key":"e_1_3_5_220_1","first-page":"32","article-title":"Development and Validation of Stability-Indicating HPTLC Method for Simultaneous Estimation of Metformin, Saxagliptin, and Dapagliflozin in Their Combined Matrix Using AQbD","volume":"12","author":"Saloni D.","year":"2022","unstructured":"Saloni, D.; Rajnikant, M.; Suhagia, B.; Hemang, D. Development and Validation of Stability-Indicating HPTLC Method for Simultaneous Estimation of Metformin, Saxagliptin, and Dapagliflozin in Their Combined Matrix Using AQbD. Bull Env Pharm Life Sci 2022, 12, 32\u201342.","journal-title":"Bull Env Pharm Life Sci"},{"key":"e_1_3_5_221_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-024-00015-9"},{"key":"e_1_3_5_222_1","first-page":"3643","article-title":"Development and Validation of HPTLC Method for Simultaneous Quantification of Dapagliflozin and Vildagliptin in Tablet Dosage Form","volume":"13","author":"Prajapati P.","year":"2023","unstructured":"Prajapati, P.; Kapupara, P. Development and Validation of HPTLC Method for Simultaneous Quantification of Dapagliflozin and Vildagliptin in Tablet Dosage Form. J Chem Health Risks 2023, 13, 3643\u20133649.","journal-title":"J Chem Health Risks"},{"key":"e_1_3_5_223_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.31788\/RJC.2025.1819089","article-title":"Development and Validation of HPTLC Method for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate, Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride Using DoE Approach","volume":"18","author":"Patel A.","year":"2025","unstructured":"Patel, A.; Patel, P. Development and Validation of HPTLC Method for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate, Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride Using DoE Approach. Rasayan J. Chem 2025, 18, 309\u2013317.","journal-title":"Rasayan J. Chem"},{"key":"e_1_3_5_224_1","first-page":"1037","article-title":"Development and Validation of Green HPTLC Method for Simultaneous Determination of Dapagliflozin and Linagliptin in Combined Dosage Form","volume":"47","author":"Dhyey S.","year":"2024","unstructured":"Dhyey, S.; Dhananjay, M.; Dhara, P.; Prasanna, P.; Grishma, P. Development and Validation of Green HPTLC Method for Simultaneous Determination of Dapagliflozin and Linagliptin in Combined Dosage Form. Bull Pharm Sci Assiut Univ 2024, 47, 1037\u20131048.","journal-title":"Bull Pharm Sci Assiut Univ"},{"key":"e_1_3_5_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202300132"},{"key":"e_1_3_5_226_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmae038"},{"key":"e_1_3_5_227_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412913666170918160514"},{"key":"e_1_3_5_228_1","first-page":"26","article-title":"Development and Validation of HPTLC Method for Estimation of Teneligliptin Hydrobromide Hydrate in Tablet Dosage Form","volume":"3","author":"Lodha S.","year":"2016","unstructured":"Lodha, S.; Patel, K.; Patel, S.; Patel, S.; Bodiwala, K.; Shah, S.; Kalyankar, G. Development and Validation of HPTLC Method for Estimation of Teneligliptin Hydrobromide Hydrate in Tablet Dosage Form. J Pharm Appl Sci 2016, 3, 26\u201333.","journal-title":"J Pharm Appl Sci"},{"key":"e_1_3_5_229_1","doi-asserted-by":"publisher","DOI":"10.25135\/jcm.55.20.11.1893"},{"key":"e_1_3_5_230_1","doi-asserted-by":"publisher","DOI":"10.53879\/id.55.10.11059"},{"key":"e_1_3_5_231_1","first-page":"1","article-title":"Development and Validation of High-Performance Thin-Layer Chromatography Method for Estimation of Teneligliptin in Bulk and In Pharmaceutical Formulation","volume":"7","author":"Prafulla P.","year":"2017","unstructured":"Prafulla, P.; Pritam, J.; Sanjay, S.; Swati, Y. Development and Validation of High-Performance Thin-Layer Chromatography Method for Estimation of Teneligliptin in Bulk and In Pharmaceutical Formulation. Acta Chim Pharm Indica 2017, 7, 1\u20138.","journal-title":"Acta Chim Pharm Indica"},{"key":"e_1_3_5_232_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00746-7"},{"key":"e_1_3_5_233_1","first-page":"54","article-title":"Validated HPTLC Method For Simultaneous Determination of Metformin Hydrochloride and Glibenclamide in Combined Dosage Form","volume":"9","author":"Malgundkar S.","year":"2014","unstructured":"Malgundkar, S.; Mulla, S. Validated HPTLC Method For Simultaneous Determination of Metformin Hydrochloride and Glibenclamide in Combined Dosage Form. IOSR J Pharm Biol Sci 2014, 9, 54\u201359.","journal-title":"IOSR J Pharm Biol Sci"},{"key":"e_1_3_5_234_1","first-page":"317","article-title":"Development and Validation of HPTLC Method for Simultaneous Estimation and Stability Indicating Study of Metformin HCl and Linagliptin in Pharmaceutical Formulation","volume":"12","author":"Rajasekaran A.","year":"2014","unstructured":"Rajasekaran, A.; Kavitha, R.; Arivukkarasu, R. Development and Validation of HPTLC Method for Simultaneous Estimation and Stability Indicating Study of Metformin HCl and Linagliptin in Pharmaceutical Formulation. World J Pharm Sci 2014, 12, 317\u2013327.","journal-title":"World J Pharm Sci"},{"key":"e_1_3_5_235_1","doi-asserted-by":"publisher","DOI":"10.47191\/ijcsrr\/v7-i8-80"},{"key":"e_1_3_5_236_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac902643v"},{"key":"e_1_3_5_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2005.11.132"},{"key":"e_1_3_5_238_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c09520"},{"key":"e_1_3_5_239_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-12605-3"},{"key":"e_1_3_5_240_1","doi-asserted-by":"publisher","DOI":"10.22456\/2527-2616.128661"},{"key":"e_1_3_5_241_1","doi-asserted-by":"publisher","DOI":"10.1515\/chem-2025-0188"},{"key":"e_1_3_5_242_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c04927"},{"key":"e_1_3_5_243_1","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.3390\/molecules27196190","article-title":"Development of UPLC-MS\/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats","volume":"27","author":"Xueru H.","year":"2022","unstructured":"Xueru, H.; Ying, L.; Yinling, M.; Yuhao, F.; Xuejiao, X.; Yanjun, C.; Zhanjun, D. Development of UPLC-MS\/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats. Molecules 2022, 27, 6190.","journal-title":"Molecules"},{"key":"e_1_3_5_244_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s43094-023-00503-2","article-title":"A Stability Indicating UPLC Method Development and Validation for the Simultaneous Estimation of Nateglinide and Metformin Hydrochloride in Bulk and Tablet Dosage Form","volume":"9","author":"Narikimalli A.","year":"2023","unstructured":"Narikimalli, A.; Galla, R. A Stability Indicating UPLC Method Development and Validation for the Simultaneous Estimation of Nateglinide and Metformin Hydrochloride in Bulk and Tablet Dosage Form. Future J Pharm Sci 2023, 9, 55.","journal-title":"Future J Pharm Sci"},{"key":"e_1_3_5_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.05.026"},{"key":"e_1_3_5_246_1","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.3390\/molecules25204625","article-title":"Bioanalytical Method Using Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPL-CHRMS) for the Detection of Metformin in Human Plasma","volume":"25","author":"Ye-Ji K.","year":"2020","unstructured":"Ye-Ji, K.; Hyeon-Cheol, J.; Tae-Eun, K.; Kwang-Hee, S. Bioanalytical Method Using Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPL-CHRMS) for the Detection of Metformin in Human Plasma. Molecules 2020, 25, 4625.","journal-title":"Molecules"},{"key":"e_1_3_5_247_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00635-X"},{"key":"e_1_3_5_248_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-020-02759-6"},{"key":"e_1_3_5_249_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826076.2019.1590208"},{"key":"e_1_3_5_250_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.70042"}],"container-title":["Critical Reviews in Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2026.2623483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:59:17Z","timestamp":1771066757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408347.2026.2623483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":249,"alternative-id":["10.1080\/10408347.2026.2623483"],"URL":"https:\/\/doi.org\/10.1080\/10408347.2026.2623483","relation":{},"ISSN":["1040-8347","1547-6510"],"issn-type":[{"value":"1040-8347","type":"print"},{"value":"1547-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}